Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis

A multicenter study in China

Bibliographic Data

ID22073640
AuthorsQiping Ge (Capital Medical University), Yan Ma (0000-0001-9735-5868, Chinese Academy of Medical Sciences & Peking Union Medical College), Lijie Zhang (0000-0002-9435-9799, Capital Medical University), Liping Ma (0000-0002-1646-6767, Henan Provincial Center for Disease Control and Prevention), Caiyan Zhao (0000-0001-5997-4641, Beijing Chest Hospital), Yuhui Chen (0000-0002-3498-0057, Center for Tuberculosis Control of Guangdong Province), Xuerui Huang (Capital Medical University), Wei Shu (0000-0002-9853-3037, Capital Medical University), Shengyu Chen (0009-0006-9576-9841), Sheng-Yu Chen (0000-0003-4782-9994, Center for Tuberculosis Control of Guangdong Province), Fei Wang (0000-0003-0860-6317, Inner Mongolia People's Hospital), Bo Li (0000-0002-7801-0319, Beijing Center for Disease Prevention and Control), Xiqin Han (Capital Medical University), Lian Shi (Shenyang 242 Hospital), Xin Wang (0000-0003-2833-6940, Heilongjiang Center for Tuberculosis Control and Prevention), Youlun Li (The Affiliated Yongchuan Hospital of Chongqing Medical University), Shangpeng Yang (0009-0002-0576-7297, Jingzhou Central Hospital), Wenli Cao (Beijing Geriatric Hospital), Qianying Liu (0000-0003-2008-1082, Chinese PLA General Hospital), Ling Chen (0000-0002-1725-4942, Zunyi Medical University), Chao Wu (0000-0002-3490-1435, Jiangsu University), Bing Ouyang (0000-0003-4663-8088, Kunming Third People's Hospital), Furong Wang (0000-0001-8693-7301, Inner Mongolia People's Hospital), Po Li (0009-0008-7359-0642, Baogang Group (China)), Xiang Wu (0000-0001-8757-4442, First People’s Hospital of Jingmen), Xiue Xi (First Affiliated Hospital of Xinxiang Medical University), Xueyan Leng (Qinhuangdao Second Hospital), Haiqing Zhang (0000-0002-4032-4080, Jiangsu University), Hua Li (0000-0002-1778-8071, The Fourth People's Hospital), Juan Li (0000-0002-8639-6100, Guangxi Center for Disease Prevention and Control), Chengqing Yang (Wuhan Pulmonary Hospital), Peng Zhang (0000-0001-6953-800X, Tangshan People's Hospital), Hongzhe Cui (Yanbian University), Yuhong Liu (0000-0002-6872-6284, Capital Medical University), Chengcheng Kong (Beijing Chest Hospital), Zhaogang Sun (Beijing Chest Hospital), Jian Du (0000-0001-8436-778X, Capital Medical University), Weiwei Gao (0000-0001-5196-4887, Capital Medical University)
Year2023
Volume11
Pages1039399-1039399
Publication date2023-01-26
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2023.1039399
PMID36778546
OpenAlexW4318066233
LanguageEN
References cited18

Background and objective Retreatment pulmonary tuberculosis (PTB) still accounts for a large proportion of tuberculosis, and the treatment outcome is unfavorable. The recurrence of retreatment PTB based on long-term follow-up has not been well demonstrated. This study aimed to evaluate effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis. Methods This multicenter cohort study was conducted in 29 hospitals from 23 regions of China from July 1, 2009, to December 31, 2020. Patients were divided into two treatment regimen groups including experimental group [modified regimen (4H-Rt2-E-Z-S(Lfx)/4H-Rt2-E)]and control group [standard regimen (2H-R-E-Z-S/6H-R-E or 3H-R-E-Z/6H-R-E)]. The patients enrolled were followed up of 56 months after successful treatment. We compared the treatment success rate, treatment failure rate, adverse reaction rate, and recurrence rate between two regimens. Multivariate Cox regression model was used to identify the potential risk factors for recurrence after successful treatment with proportional hazards assumptions tested for all variables. Results A total of 381 patients with retreatment PTB were enrolled, including 244 (64.0%) in the experimental group and 137 (36.0%) in the control group. Overall, the treatment success rate was significant higher in the experimental group than control group (84.0 vs. 74.5%, P = 0.024); no difference was observed in adverse reactions between the two groups (25.8 vs. 21.2%, P > 0.05). A total of 307 patients completed the 56 months of follow-up, including 205 with the modified regimen and 102 with the standard regimen. Among these, 10 cases (3.3%) relapsed, including 3 in the experimental group and 7 in the control group (1.5% vs 6.9%, P = 0.035). Reduced risks of recurrence were observed in patients treated with the modified regimen compared with the standard regimen, and the adjusted hazard ratio was 0.19 (0.04–0.77). Conclusion The modified retreatment regimen had more favorable treatment effects, including higher treatment success rate and lower recurrence rate in patients with retreated drug-sensitive PTB

Adverse effect · Multivariate analysis · Proportional hazards model · Regimen · Tuberculosis · Diagnosis and treatment of tuberculosis · Infectious Diseases and Tuberculosis · Medicine · Tuberculosis Research and Epidemiology · Internal Medicine · Surgery

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae